COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,788 Articles (22,946 medRxiv, 8,842 bioRxiv)

Most recent first Previous |  Page 386: Articles 3851-3860  | Next

Synthesis, Insertion and Characterization of SARS-CoV-2 Membrane Protein Within Lipid Bilayers
Zhang, Y., Anbir, S., Mctiernan, J., Li, S., Worcester, M., Mishra, P., Colvin, M. E., Gopinathan, A., Mohideen, U., Zandi, R., Kuhlman, T. E.
10.1101/2023.09.30.560318 — Posted: 2023-10-02
Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults
Nash, D., Srivastava, A., Shen, Y., Penrose, K., Kulkarni, S., Zimba, R., You, W., Berry, A., Mirzayi, C., Maroko, A. R., Parcesepe, A., Grov, C., Robertson, M.
10.1101/2023.09.29.23296142 — Posted: 2023-10-02
COVID-related Excess Missed HIV Diagnoses in the United States in 2021: Follow-up to 2020
Viguerie, A., Song, R., Satcher Johnson, A., Lyles, C. M., Hernandez, A., Farnham, P. G.
10.1101/2023.09.28.23296285 — Posted: 2023-09-29
The more symptoms the better? Covid-19 vaccine side effects and long-term neutralizing antibody response
Dutcher, E. G., Epel, E. S., Mason, A. E., Hecht, F. M., Robinson, J. E., Drury, S. S., Prather, A. A.
10.1101/2023.09.26.23296186 — Posted: 2023-09-29
Influence of age, sex, body habitus, vaccine type and anti-S serostatus on cellular and humoral responses to SARS-CoV-2 vaccination
Chambers, E. S., Cai, W., Cousens, A. K., Vivaldi, G., Jolliffe, D. A., Perdek, N., Li, W., Faustini, S. E., Gibbons, J. M., Pade, C., Richter, A. G., Martineau, A. R.
10.1101/2023.09.29.23296222 — Posted: 2023-09-29
Prevalence of COVID-19 and long COVID - Results from the 2022 Behavioral Risk Factor Surveillance System, 50 states.
Adams, M. L., Grandpre, J.
10.1101/2023.09.29.23296352 — Posted: 2023-09-29
Endemic means change as SARS-CoV-2 evolves
Otto, S., MacPherson, A., Colijn, C.
10.1101/2023.09.28.23296264 — Posted: 2023-09-29
Curcumin and turmeric extract inhibited SARS-CoV-2 pseudovirus cell entry and Spike mediated cell fusion
Septisetyani, E. P. P., Lestari, D., Paramitasari, K. A., Prasetyaningrum, P. W., Kastian, R. F., Santoso, A., Eriani, K.
10.1101/2023.09.28.560070 — Posted: 2023-09-29
POP-UP TCR: Prediction of Previously Unseen Paired TCR-pMHC
Tickotsky, N.
10.1101/2023.09.28.560071 — Posted: 2023-09-29
Protective non-neutralizing mAbs targets conserved opsonic epitopes on SARS-CoV-2 variants
Izadi, A., Godzwon, M., Ohlin, M., Nordenfelt, P.
10.1101/2023.09.29.560084 — Posted: 2023-09-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).